▶ 調査レポート

世界の骨&関節用健康サプリメント市場(~2027):種類別、形態別、流通チャネル別、地域別

• 英文タイトル:Bone & Joint Health Supplements Market Research Report by Type, Form, Distribution Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の骨&関節用健康サプリメント市場(~2027):種類別、形態別、流通チャネル別、地域別 / Bone & Joint Health Supplements Market Research Report by Type, Form, Distribution Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2305C141資料のイメージです。• レポートコード:MRC2305C141
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、240ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:食品
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、2021年に118.7億ドルであった世界の骨&関節用健康サプリメント市場規模が、2022年には130.4億ドルに成長し、その後年平均10.12%拡大して2027年には211.7億ドルに達すると予測しています。本調査資料では、骨&関節用健康サプリメントの世界市場について総合的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(カルシウム、コラーゲン、グルコサミンコンドロイチン、オメガ3脂肪酸、ビタミンD)分析、形態別(カプセル、液体、粉末、錠剤)分析、流通チャネル別(健康&美容ショップ、薬局&ドラッグストア、スーパーマーケット/ハイパーマーケット)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容をまとめました。なお、本書内の企業情報には、Amway Corporation、Arazo Nutrition、Archer Daniels Midland、Basf SE、Bayer AG、Bellavita Healthcare Pvt Ltd、Glanbia Plc、Herbs Nutriproducts Pvt. Ltd.、Love Life Supplements Ltd.、Nature's Sunshine Products, Inc.、NOW Health Group, Inc.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の骨&関節用健康サプリメント市場規模:種類別
- カルシウムの市場規模
- コラーゲンの市場規模
- グルコサミンコンドロイチンの市場規模
- オメガ3脂肪酸の市場規模
- ビタミンDの市場規模
・世界の骨&関節用健康サプリメント市場規模:形態別
- カプセルの市場規模
- 液体の市場規模
- 粉末の市場規模
- 錠剤の市場規模
・世界の骨&関節用健康サプリメント市場規模:流通チャネル別
- 健康&美容ショップチャネルの市場規模
- 薬局&ドラッグストアチャネルの市場規模
- スーパーマーケット/ハイパーマーケットチャネルの市場規模
・世界の骨&関節用健康サプリメント市場規模:地域別
- 南北アメリカの骨&関節用健康サプリメント市場規模
アメリカの骨&関節用健康サプリメント市場規模
カナダの骨&関節用健康サプリメント市場規模
ブラジルの骨&関節用健康サプリメント市場規模
...
- アジア太平洋の骨&関節用健康サプリメント市場規模
日本の骨&関節用健康サプリメント市場規模
中国の骨&関節用健康サプリメント市場規模
インドの骨&関節用健康サプリメント市場規模
韓国の骨&関節用健康サプリメント市場規模
台湾の骨&関節用健康サプリメント市場規模
...
- ヨーロッパ/中東/アフリカの骨&関節用健康サプリメント市場規模
イギリスの骨&関節用健康サプリメント市場規模
ドイツの骨&関節用健康サプリメント市場規模
フランスの骨&関節用健康サプリメント市場規模
ロシアの骨&関節用健康サプリメント市場規模
...
- その他地域の骨&関節用健康サプリメント市場規模
・競争状況
・企業情報

The Global Bone & Joint Health Supplements Market size was estimated at USD 11.87 billion in 2021 and expected to reach USD 13.04 billion in 2022, and is projected to grow at a CAGR 10.12% to reach USD 21.17 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Bone & Joint Health Supplements to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Calcium, Collagen, Glucosamine-Chondroitin, Omega-3 Fatty acids, Vitamin D, and Vitamin K.

Based on Form, the market was studied across Capsules, Liquid, Powder, and Tablets.

Based on Distribution Channels, the market was studied across Health & Beauty stores, Pharmacies & Drug stores, and Supermarkets/Hypermarkets.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bone & Joint Health Supplements market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bone & Joint Health Supplements Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bone & Joint Health Supplements Market, including Amway Corporation, Arazo Nutrition, Archer Daniels Midland, Basf SE, Bayer AG, Bellavita Healthcare Pvt Ltd, Glanbia Plc, Herbs Nutriproducts Pvt. Ltd., Love Life Supplements Ltd., Nature’s Sunshine Products, Inc., NOW Health Group, Inc., Nutramax Laboratories Consumer Care, Inc, Nutravita Limited, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group plc, Simply Supplements, Vita Life Sciences Ltd, Vitaco Ltd, and Vitawin.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Bone & Joint Health Supplements Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bone & Joint Health Supplements Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bone & Joint Health Supplements Market?
4. What is the competitive strategic window for opportunities in the Global Bone & Joint Health Supplements Market?
5. What are the technology trends and regulatory frameworks in the Global Bone & Joint Health Supplements Market?
6. What is the market share of the leading vendors in the Global Bone & Joint Health Supplements Market?
7. What modes and strategic moves are considered suitable for entering the Global Bone & Joint Health Supplements Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of vitamin D deficiencies globally
5.1.1.2. Shift in consumer preferences due to the rising health awareness
5.1.1.3. Aging population and rising number of osteoporosis patients
5.1.2. Restraints
5.1.2.1. High R&D investments and high cost of clinical trials
5.1.3. Opportunities
5.1.3.1. Innovations in the nutritional supplements and exploration of multifunctional properties of products
5.1.3.2. Rapidly increasing role of biomedicine for joint pain
5.1.4. Challenges
5.1.4.1. Consumer skepticism associated with nutraceutical products
5.2. Cumulative Impact of COVID-19

6. Bone & Joint Health Supplements Market, by Type
6.1. Introduction
6.2. Calcium
6.3. Collagen
6.4. Glucosamine-Chondroitin
6.5. Omega-3 Fatty acids
6.6. Vitamin D
6.7. Vitamin K

7. Bone & Joint Health Supplements Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Liquid
7.4. Powder
7.5. Tablets

8. Bone & Joint Health Supplements Market, by Distribution Channels
8.1. Introduction
8.2. Health & Beauty stores
8.3. Pharmacies & Drug stores
8.4. Supermarkets/Hypermarkets

9. Americas Bone & Joint Health Supplements Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bone & Joint Health Supplements Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bone & Joint Health Supplements Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Amway Corporation
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Arazo Nutrition
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Archer Daniels Midland
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Basf SE
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bayer AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Bellavita Healthcare Pvt Ltd
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Glanbia Plc
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Herbs Nutriproducts Pvt. Ltd.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Love Life Supplements Ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Nature’s Sunshine Products, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. NOW Health Group, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Nutramax Laboratories Consumer Care, Inc
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Nutravita Limited
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Pfizer Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Procter & Gamble Company
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Reckitt Benckiser Group plc
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Simply Supplements
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Vita Life Sciences Ltd
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Vitaco Ltd
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Vitawin
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing